Program stifles cost increases
Managed care principles used to save billions in Medicaid costs in Pennsylvania.
HARRISBURG, PA.-Pennsylvania has saved $2.7 billion during the past five years as a result of applying managed care principles to Medicaid through its HealthChoices Program, an analysis by the Lewin Group said.
The program has also done a better job at holding down annual increases in medical costs compared with fee-for-service, Pennsylvania's traditional Medicaid program, according to the report, which was commissioned by the Pennsylvania Coalition of Medical Assistance Managed Care Organizations.
The report focused on four areas:
"We've been able to negotiate rates with the provider community that make sense in the cost structure of [Medicaid]," he says. "We're also able to utilize education programs that talk directly to our members about how to manage significant disease states like diabetes, asthma and obesity."
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
